Voriconazole-induced neuropathy

Chemotherapy

Volumn 54, Issue 3, 2008, Pages 224-227

  Aksoy, Firdevs ^a   Akdogan, Elif ^a   Aydin, Kemalettin ^a   Yilmaz, Mustafa ^a   Altunayoglu, Vildan ^a   Sozen, Ebru Emel ^a   Omay, Serdar Bedii ^a   Koksal, Iftihar ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Fungal infection; Neuropathy; Voriconazole

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; VORICONAZOLE;

ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPERGILLOSIS; BIOPSY; CANCER CHEMOTHERAPY; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROMYOGRAM; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERALGESIA; MALE; MUSCLE ATROPHY; MUSCLE CRAMP; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROPATHY; PAIN; PARESTHESIA; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY; SIDE EFFECT;

ADOLESCENT; ADULT; FEMALE; HUMANS; LEUKEMIA; MALE; NERVOUS SYSTEM DISEASES; PYRIMIDINES; TRIAZOLES;

EID: 46449131940     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000140466     Document Type: Article

References (15)

1. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. N Engl J Med 2002;347:408-415.
2. Rex JH, Stevens DA: Systemic antifungal agent;in Mandell GL, Bennett JE, Dolin R (eds): Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, ed 6. Philadelphia, Churchill Livingstone, 2005, pp 502-514.
3. Herbrecht R: Voriconazole: therapeutic review of a new azole antifungal. Expert Rev Anti Infect Ther 2004;2:485-497.
4. Keady S, Thacker M: Voriconazole in the treatment of invasive fungal infections. Intensive Crit Care Nurs 2005;21:370-373.
5. Masia Canuto M, Gutierrez Rodero F: Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002;2:550-563.
6. Ghannoum MA, Kuhn DM: Voriconazole - better chances for patients with invasive mycoses. Eur J Med Res 2002;7:242-256.
7. De Pauw BE, Meunier F: The challenge of invasive fungal infection. Chemotherapy 1999;45:1-14.
8. Karthaus M, Doellmann T, Klimasch T, Elser C, Rosenthal C, Ganser A, Heil G: Intensive intravenous amphotericin B for prophylaxis of systemic fungal infections. Results of a prospective controlled pilot study in acute leukemia patients. Chemotherapy 2000;46:293-302.
9. Bosch EP, Smith BE: Disorders of peripheral nerves-toxic neuropathies;in Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds): Neurology Clinical Practice, ed 4. Philadelphia, Elsevier, 2004, pp 2299-2401.
10. Hoffman HL, Rathbun RC: Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs 2002;11:409-429.
11. Ascioglu S, et al: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
12. Johnson LB, Kauffman CA: Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630-637.
13. Tsiodras S, Zafiropoulou R, Kanta E, Demponeras C, Karandreas N, Manesis EK: Painful peripheral neuropathy associated with voriconazole use. Arch Neurol 2005;62:144-146.
14. Neundörfer B: Polyneuropathies - symptoms, causes and diagnostic procedure. Ther Umsch 1993;50:761-765.
15. Quasthoff S, Hartung HP: Chemotherapy-induced peripheral neuropathy. J Neurol 2002;249:9-17.